REG - Arix Bioscience Plc - Director/PDMR Shareholding

Arix BioscienceAnnouncement

17/12/2021 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20211217:nRSQ9556Va&default-theme=true

RNS Number : 9556V  Arix Bioscience Plc  17 December 2021

Arix Bioscience plc

Director/PDMR Shareholdings

Notification and public disclosure of transactions by persons discharging
managerial responsibilities and persons closely associated with them

 1    Details of the person discharging managerial responsibilities / person closely

    associated

 a)   Name                                                         Robert Lyne

 2    Reason for the notification

 a)   Position/status                                              CEO and General Counsel

 b)   Initial notification /Amendment                              Initial Notification

 3    Details of the issuer, emission allowance market participant, auction

    platform, auctioneer or auction monitor

 a)   Name                                                         Arix Bioscience plc

 b)   LEI                                                          213800OVT3AHQCXNIX43

 4    Details of the transaction(s): section to be repeated for (i) each type of

    instrument; (ii) each type of transaction; (iii) each date; and (iv) each
      place where transactions have been conducted
 a)   Description of the financial instrument, type of instrument  Arix Bioscience plc Ordinary shares of 0.001 pence each

      Identification code                                          GB00BD045071
 b)   Nature of the transaction                                    Share purchase

 c)   Price(s) and volume(s)

                                                                                     Price(s)          Volume(s)
                                                                                     120.00p           41,666.00
 d)   Aggregated information

      - Aggregated volume                                          N/A single transaction

      - Price                                                      £49,999.20

 e)   Date of the transaction                                      16 December 2021

 f)   Place of the transaction                                     London Stock Exchange

 

 

 1    Details of the person discharging managerial responsibilities / person closely

    associated

 a)   Name                                                         Peregrine Moncreiffe

 2    Reason for the notification

 a)   Position/status                                               Non-Executive Director and Chair of the Board

 b)   Initial notification /Amendment                              Initial Notification

 3    Details of the issuer, emission allowance market participant, auction

    platform, auctioneer or auction monitor

 a)   Name                                                         Arix Bioscience plc

 b)   LEI                                                          213800OVT3AHQCXNIX43

 4    Details of the transaction(s): section to be repeated for (i) each type of

    instrument; (ii) each type of transaction; (iii) each date; and (iv) each
      place where transactions have been conducted
 a)   Description of the financial instrument, type of instrument  Arix Bioscience plc Ordinary shares of 0.001 pence each

      Identification code                                          GB00BD045071
 b)   Nature of the transaction                                    Share purchase

 c)   Price(s) and volume(s)

                                                                                     Price(s)          Volume(s)
                                                                                     119.00p           84,000.00
 d)   Aggregated information

      - Aggregated volume                                          N/A single transaction

      - Price                                                      £99,959.98

 e)   Date of the transaction                                      16 December 2021

 f)   Place of the transaction                                     London Stock Exchange

 

 

 1    Details of the person discharging managerial responsibilities / person closely

    associated

 a)   Name                                                          Sir Michael Bunbury

 2    Reason for the notification

 a)   Position/status                                               Non-Executive Director and Senior Independent Director (SID)

 b)   Initial notification /Amendment                              Initial Notification

 3    Details of the issuer, emission allowance market participant, auction

    platform, auctioneer or auction monitor

 a)   Name                                                         Arix Bioscience plc

 b)   LEI                                                          213800OVT3AHQCXNIX43

 4    Details of the transaction(s): section to be repeated for (i) each type of

    instrument; (ii) each type of transaction; (iii) each date; and (iv) each
      place where transactions have been conducted
 a)   Description of the financial instrument, type of instrument  Arix Bioscience plc Ordinary shares of 0.001 pence each

      Identification code                                          GB00BD045071
 b)   Nature of the transaction                                    Share purchase

 c)   Price(s) and volume(s)

                                                                                     Price(s)          Volume(s)
                                                                                     119.00p           40,000.00
 d)   Aggregated information

      - Aggregated volume                                          N/A single transaction

      - Price                                                      £47,600.00

 e)   Date of the transaction                                      16 December 2021

 f)   Place of the transaction                                     London Stock Exchange

For further information please contact:

Derringtons Limited, Company Secretary
+44 20 8819 6486

 

Ends.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHDQLFFFLLXFBQ